← SELECT MEDICAL HOLDINGS CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.2b |
$4.4b
+3.50%
|
$5.1b
+16.40%
|
$5.5b
+7.33%
|
$5.5b
+1.43%
|
$6.2b
+12.16%
|
$6.3b
+2.08%
|
$6.7b
+5.22%
|
$5.2b
-22.16%
|
$5.5b
+5.12%
|
$5.5b
+1.25%
|
|
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $3.7b |
$3.7b
+1.91%
|
$4.3b
+16.22%
|
$4.6b
+6.91%
|
$4.7b
+1.49%
|
$5.3b
+12.20%
|
$5.6b
+5.96%
|
$5.7b
+2.35%
|
$4.6b
-20.56%
|
$4.8b
+5.93%
|
$4.9b
+1.52%
|
|
| Interest Income (Expense), Net | — | ($154.7m) | — | — | — | — | — | — | — | — | — | |
| Gross Profit | $552.1m |
$629.9m
+14.10%
|
$740.2m
+17.50%
|
$812.9m
+9.82%
|
$821.3m
+1.04%
|
$919.4m
+11.93%
|
$733.4m
-20.23%
|
$932.0m
+27.09%
|
$633.6m
-32.02%
|
$629.3m
-0.69%
|
$624.2m
-0.81%
|
|
| General and Administrative Expense | $106.9m | $114.0m | $121.3m | $128.5m | $138.0m | $147.0m | $153.0m | $170.2m | $225.9m | $154.4m | $160.8m | |
| Amortization of Intangible Assets | — | — | — | $29.6m | $27.6m | $29.5m | $31.0m | $31.7m | $1.6m | $1.6m | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | $299.8m |
$355.9m
+18.69%
|
$417.3m
+17.25%
|
$471.9m
+13.09%
|
$567.7m
+20.30%
|
$713.8m
+25.74%
|
$403.3m
-43.50%
|
$554.9m
+37.59%
|
$268.3m
-51.64%
|
$336.2m
+25.29%
|
$321.8m
-4.26%
|
|
| Other Operating Income (Expense), Net | — | — | $0 | $0 | $90.0m | $144.0m | $28.8m | $1.8m | $3.4m | $1.6m | — | |
| Interest Expense (non-operating) | $170.1m | $154.7m | $198.5m | $200.6m | $153.0m | $136.0m | $169.1m | $198.6m | $128.6m | $117.9m | $117.2m | |
| Income (Loss) from Equity Method Investments | $19.9m | $21.1m | $21.9m | $25.0m | $29.4m | $44.4m | $26.4m | $40.8m | $60.2m | $54.5m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $180.7m | $202.5m | $235.6m | $264.7m | $456.5m | $629.7m | $260.6m | $382.4m | $174.8m | $272.7m | $258.7m | |
| Current Income Tax Expense (Benefit) | $68.1m | $54.1m | $51.4m | $71.2m | $126.6m | $124.7m | $55.0m | $98.7m | $75.7m | $27.6m | $55.1m | |
| Income Tax Expense (Benefit) | $55.5m | ($18.2m) | $58.6m | $63.7m | $111.9m | $129.8m | $62.6m | $82.6m | $44.8m | $58.2m | $55.1m | |
| Net Income (Loss) Attributable to Parent | $115.4m |
$177.2m
+53.52%
|
$137.8m
-22.21%
|
$148.4m
+7.70%
|
$259.0m
+74.47%
|
$402.2m
+55.30%
|
$159.0m
-60.47%
|
$243.5m
+53.14%
|
$214.0m
-12.10%
|
$146.2m
-31.69%
|
$130.1m
-11.00%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $111.9m |
$171.4m
+53.21%
|
$133.3m
-22.25%
|
$143.5m
+7.63%
|
$250.1m
+74.34%
|
$388.8m
+55.45%
|
$153.4m
-60.55%
|
$234.7m
+53.03%
|
$214.0m
-8.81%
|
$146.2m
-31.69%
|
$130.1m
-11.00%
|
|
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic | $299.8m | $355.9m | $417.3m | $471.9m | $567.7m | $713.8m | $403.3m | $554.9m | $63.2m | $142.9m | $130.1m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $9.9m | $43.5m | $39.1m | $52.6m | $85.6m | $97.7m | $39.0m | $56.2m | $82.7m | $68.3m | $130.1m | |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | $9.9m | $7.8m | $11.3m | ($26.6m) | ($47.9m) | ($47.6m) | ($31.5m) | ($48.2m) | ($73.3m) | ($62.9m) | $130.1m | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | $3.5m | $5.8m | $4.6m | $5.0m | $8.9m | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $0.88 | $1.33 | $1.02 | $1.10 | $1.93 | $2.98 | $1.23 | $1.91 | $1.66 | $1.16 | $1.07 | |
| Earnings Per Share, Diluted | $0.87 | $1.33 | $1.02 | $1.10 | $1.93 | $2.98 | $1.23 | $1.91 | $1.66 | $1.16 | $1.07 | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | — | — | — | ($0) | $0 | $1 | $1 | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | — | — | ($0) | $0 | $1 | $1 | — | |
| Common Stock, Dividends, Per Share, Declared | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 | $0.50 | $0.50 | $0.50 | $0.25 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 127.8m | 129.0m | 130.2m | 130.2m | 129.8m | 130.2m | 124.6m | 123.1m | 124.6m | 122.6m | 121.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 128.0m | 129.1m | 130.3m | 130.3m | 129.8m | 130.2m | 124.6m | 123.1m | 124.6m | 122.6m | 121.3m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $4.0b | $4.1b | $4.7b | $5.0b | $5.1b | $5.6b | $6.0b | $6.1b | $4.9b | $5.1b | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $55.5m | $18.2m | $58.6m | $63.7m | $111.9m | $129.8m | $62.6m | $82.6m | $65.5m | $146.2m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $55.5m | $18.2m | $58.6m | $63.7m | $111.9m | $129.8m | $62.6m | $82.6m | $130.0m | $214.5m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | $174.0m | $184.5m | $166.7m | $0 | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | $174.0m | $184.5m | $148.6m | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.